Paulina Selaru

Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis

Alice T. Shaw, Beow Y. Yeap, Benjamin Solomon et al. · The Lancet Oncology · 2011 · 900 citations

Medicine, Oncology, Pharmacology +14

Clinical Experience With Crizotinib in Patients With Advanced <i>ALK</i>-Rearranged Non–Small-Cell Lung Cancer and Brain Metastases

Daniel B. Costa, Alice T. Shaw, Sai‐Hong Ignatius Ou et al. · Journal of Clinical Oncology · 2015 · 605 citations · Full text

Medicine, Oncology, Pharmacology +14

Acute Hemodynamic Effects of Conivaptan, a Dual V _1A and V ₂ Vasopressin Receptor Antagonist, in Patients With Advanced Heart Failure

James E. Udelson, William Smith, G Hendrix et al. · Circulation · 2001 · 363 citations · Full text

Medicine, Cardiology, Pharmacology +17

Multicenter, Phase II Trial of Sunitinib in Previously Treated, Advanced Non–Small-Cell Lung Cancer

Mark A. Socinski, Silvia Novello, Julie R. Brahmer et al. · Journal of Clinical Oncology · 2008 · 321 citations · Full text

Medicine, Oncology, Pharmacology +17

Intracranial Efficacy of Crizotinib Versus Chemotherapy in Patients With Advanced <i>ALK</i>-Positive Non–Small-Cell Lung Cancer: Results From PROFILE 1014

Benjamin Solomon, Federico Cappuzzo, Enriqueta Felip et al. · Journal of Clinical Oncology · 2016 · 271 citations

Medicine, Oncology, Pharmacology +13